Celularity Incorporated
Clinical trials sponsored by Celularity Incorporated, explained in plain language.
A clinical-stage biotechnology company developing allogeneic cell therapies from placental stem cells.
Trade on eToro (ad)Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
Placenta cells could tame Crohn's inflammation
Disease control CompletedThis trial investigates whether intravenous infusions of cells from the human placenta (PDA001) can reduce inflammation and improve symptoms in adults with moderate-to-severe Crohn's disease. Participants receive either one of three doses of PDA001 or a placebo, and researchers t…
Phase: PHASE2 • Sponsor: Celularity Incorporated • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Placenta cell shots aim to heal diabetic foot ulcers
Disease control CompletedThis early study tested whether injections of cells from donated placentas are safe for people with blocked leg arteries and diabetic foot ulcers. Fifteen adults with diabetes received one of several doses. The main goal was to check for side effects and find the safest dose. Thi…
Phase: PHASE1 • Sponsor: Celularity Incorporated • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC